|
[1]
|
Collaborators GBDHB (2022) Global, Regional, and National Burden of Hepatitis B, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet Gastroenterology and Hepatology, 7, 796-829. [Google Scholar] [CrossRef]
|
|
[2]
|
Le, M.H., Yeo, Y.H., Li, X., et al. (2022) 2019 Global NAFLD Prevalence: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 20, 2809-2817.e28. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Li, J., Zou, B., Yeo, Y.H., et al. (2019) Prevalence, Incidence, and Outcome of Non-Alcoholic Fatty Liver Disease in Asia, 1999-2019: A Systematic Review and Me-ta-Analysis. The Lancet Gastroenterology and Hepatology, 4, 389-398. [Google Scholar] [CrossRef]
|
|
[4]
|
Zheng, Y., Xu, K., Hu, H., et al. (2021) Prevalence and In-cidence of Non-Alcohol Fatty Liver Disease in Chronic Hepatitis B Population in Southeast China: A Community-Based Study. Frontiers in Medicine (Lausanne), 8, Article ID: 683872. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Pais, R., Rusu, E., Zilisteanu, D., et al. (2015) Prevalence of Stea-tosis and Insulin Resistance in Patients with Chronic Hepatitis B Compared with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease. European Journal of Internal Medicine, 26, 30-36. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Zheng, Q., Zou, B., Wu, Y., et al. (2021) Systematic Review with Meta-Analysis: Prevalence of Hepatic Steatosis, Fibrosis and Associated Factors in Chronic Hepatitis B. Alimentary Pharmacology & Therapeutics, 54, 1100-1109. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
王贵强, 段钟平, 王福生, 等. 慢性乙型肝炎防治指南(2019年版) [J]. 实用肝脏病杂志, 2020, 23(1): 9-32.
|
|
[8]
|
Chalasani, N., Younossi, Z., Lavine, J.E., et al. (2018) The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology, 67, 328-357. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Wong, V.W., Chu, W.C., Wong, G.L., et al. (2012) Prevalence of Non-Alcoholic Fatty Liver Disease and Advanced Fibrosis in Hong Kong Chinese: A Population Study Using Pro-ton-Magnetic Resonance Spectroscopy and Transient Elastography. Gut, 61, 409-415. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Younossi, Z.M. (2019) Non-Alcoholic Fatty Liver Disease—A Global Public Health Perspective. Journal of Hepatology, 70, 531-544. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Gao, H., Kuang, Z., Zhong, C.X., et al. (2019) Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in Patients with Chronic Hepatitis B Receiving Antiviral Therapy. Chinese Journal of Hepatology, 27, 347-351.
|
|
[12]
|
Targher, G., Byrne, C.D., Lonardo, A., et al. (2016) Non-Alcoholic Fatty Liver Disease and Risk of Incident Cardiovascular Disease: A Meta-Analysis. Journal of Hepatology, 65, 589-600. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Lee, S.B., Park, G.M., Lee, J.Y., et al. (2018) Association between Non-Alcoholic Fatty Liver Disease and Subclinical Coronary Atherosclerosis: An Observational Cohort Study. Journal of Hepatology, 68, 1018-1024. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Targher, G., Byrne, C.D. and Tilg, H. (2020) NAFLD and In-creased Risk of Cardiovascular Disease: Clinical Associations, Pathophysiological Mechanisms and Pharmacological Im-plications. Gut, 69, 1691-1705. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Kim, G.A., Lee, H.C., Choe, J., et al. (2017) Association between Non-Alcoholic Fatty Liver Disease and Cancer Incidence Rate. Journal of Hepatology.
|
|
[16]
|
Mantovani, A., Petracca, G., Beatrice, G., et al. (2022) Non-Alcoholic Fatty Liver Disease and Increased Risk of Incident Extrahepatic Cancers: A Meta-Analysis of Observational Cohort Studies. Gut, 71, 778-788. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Choi, H.S.J., Brouwer, W.P., Zanjir, W.M.R., et al. (2020) Non-alcoholic Steatohepatitis Is Associated with Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B. Hepatology, 71, 539-548. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Mak, L.Y., Hui, R.W., Fung, J., et al. (2020) Diverse Effects of Hepatic Steatosis on Fibrosis Progression and Functional Cure in Virologically Quiescent Chronic Hepatitis B. Journal of Hepa-tology, 73, 800-806. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Hui, R.W.H., Seto, W.K., Cheung, K.S., et al. (2018) Inverse Rela-tionship between Hepatic Steatosis and Hepatitis B Viremia: Results of a Large Case-Control Study. Journal of Viral Hepatitis, 25, 97-104. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Mao, X., Cheung, K.S., Peng, C., et al. (2022) Steatosis, HBV-Related HCC, Cirrhosis, and HBsAg Seroclearance: A Systematic Review and Meta-Analysis. Hepatology, 77, 1735-1745. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Wu, V.C., Chen, T.H., Wu, M., et al. (2018) Comparison of Cardiovascular Outcomes and All-Cause Mortality in Patients with Chronic Hepatitis B and C: A 13-Year Nationwide Population-Based Study in Asia. Atherosclerosis, 269, 178-184. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Ranković, I., Milivojević, V., Pavlović Marković, A., et al. (2022) Interplay between Chronic Hepatitis B and Atherosclerosis: In-novative Perspectives and Theories. World Journal of Gastroenterology, 28, 497-499. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Riveiro-Barciela, M., Marcos-Fosch, C., Martinez-Valle, F., et al. (2021) Naïve Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Are at Risk of Carotid Atherosclerosis: A Prospective Study. World Journal of Gastroenterology, 27, 5112-5125. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Ishizaka, N., Ishizaka, Y., Takahashi, E., et al. (2002) Increased Prevalence of Carotid Atherosclerosis in Hepatitis B Virus Carriers. Circulation, 105, 1028-1030. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Chun, H.S., Lee, J.S., Lee, H.W., et al. (2022) Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B. Digestive Diseases and Sciences, 67, 3412-3425. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Cheng, J.Y., Wong, V.W., Tse, Y.K., et al. (2016) Metabolic Syndrome Increases Cardiovascular Events but Not Hepatic Events and Death in Patients with Chronic Hepatitis B. Hepatology, 64, 1507-1517. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Leow, Y.W., Chan, W.K., Goh, G.B.B., et al. (2023) Hepatic Steatosis and Metabolic Risk Factors among Patients with Chronic Hepatitis B: The Multicentre, Prospective CAP-Asia Study. Journal of Viral Hepatitis, 30, 319-326. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Stahl, E.P., Dhindsa, D.S., et al. (2019) Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review. JACC: Journal of the American College of Cardiology, 73, 948-963. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Peleg, N., Issachar, A., Sneh Arbib, O., et al. (2019) Liver Steatosis Is a Strong Predictor of Mortality and Cancer in Chronic Hepatitis B Regardless of Viral Load. JHEP Reports, 1, 9-16. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Hu, D., Wang, H., Wang, H., et al. (2018) Non-Alcoholic Hepatic Steatosis Attenuates Hepatitis B Virus Replication in an HBV-Immunocompetent Mouse Model. Hepatology Interna-tional, 12, 438-446. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Chen, Y., Liu, Q., Han, J., et al. (2022) A Meta-Analysis of How Nonalcoholic Fatty Liver Disease Affect Antiviral Treatment of Patients with e Antigen-Positive Chronic Hepatitis B. Emergency Medicine International, 2022, Article ID: 4774195. [Google Scholar] [CrossRef] [PubMed]
|